Genmab — Februar 2019
-
hmmm... det var vist toppen for denne gang. synes godt nok at den ser noget slap ud. overvejer at gå på weekden med "tom tank"
-
New trial (by Shaji Kumar) Daratumumab and Dexamethasone With Pomalidomide or Carfilzomib in Treating Patients With Relapsed Multiple Myeloma https://clinicaltrials.gov/ct2/show/NCT03841565?term=daratumumab+OR+ofatumumab+OR+tisotumab+OR+arzerra+OR+darzalex&lupd_s=02%2F15%2F2019&rank=1
-
Pollux completion date extended by half a year https://clinicaltrials.gov/ct2/history/NCT02076009?A=39&B=40&C=merged
-
I think they are giving MAIA participants on (Rd) arm who have sponsor-confirmed disease progression , the option to receive daratumumab https://clinicaltrials.gov/ct2/history/NCT02252172?A=47&B=48&C=merged
-
ALL hospitals now recruiting in the HuMax-AXL-ADC trial (1 hospital removed) https://clinicaltrials.gov/ct2/history/NCT02988817?A=11&B=12&C=merged
-
-
Interessant artikel om atezo + dara https://www.medpagetoday.com/reading-room/asco/immunotherapy/78028
-
Og det må være dette forsøg der er udvidet ? https://clinicaltrials.gov/ct2/show/NCT02431208?cond=NCT02431208&rank=1
-
God morgen.
-
Ditto her i Regstrup.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind